Concert Bio uses data science and an extensive plant-microbe database to identify and supply beneficial microbes for hydroponic greenhouse operations. This platform optimizes the plant microbiome to enhance crop growth, quality, and resilience. Growers utilizing these novel microbe products have reported measurable improvements in yield performance.
Funding
$1.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Hydroponic agriculture lacks the natural soil microbiome essential for optimal plant growth, quality, and resilience. Recreating this delicate balance of microorganisms in soilless systems is a significant challenge for greenhouse growers.
Solution
Concert Bio develops microbial products tailored for hydroponic agriculture by leveraging a comprehensive microbiome database and DNA sequencing to identify beneficial microbes. Their platform unlocks a new level of understanding about the hydroponic microbiome and how to improve it. By optimizing the microbial communities in greenhouse environments, Concert Bio enhances crop growth, quality, and resilience.
Target Audience
Concert Bio's primary customers are hydroponic greenhouse growers seeking to improve crop yield, quality, and resilience through optimized microbial solutions.
Features
- First-of-their-kind microbe products based on species never before tried on plants.
- Products developed from years of real-world data from over 30 growers worldwide.
- DNA sequencing identifies all pathogens and beneficial species in the microbiome.
- Microbiome monitoring service provides access to Concert Bio's expertise through regular consultations.
- All equipment needed to collect and send samples is provided for the monitoring service.